Rocket One Inc. Other Selling, General and Administrative Expense
Rocket One Inc. (RKTO) reported Other Selling, General and Administrative Expense of $67.10 thousand for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherSellingGeneralAndAdministrativeExpense · last filed 2023-11-13
- Rocket One Inc. other selling, general and administrative expense for the quarter ending 2023-09-30 was $67.10K, a 80.92% decline year-over-year.
- Rocket One Inc. other selling, general and administrative expense for the quarter ending 2023-06-30 was $46.17K, a 80.57% decline year-over-year.
- Rocket One Inc. other selling, general and administrative expense for the quarter ending 2023-03-31 was $326.88K, a 53.70% increase year-over-year.
- Rocket One Inc. other selling, general and administrative expense for the quarter ending 2022-12-31 was $182.75K, a 1.85% increase year-over-year.
- Rocket One Inc. other selling, general and administrative expense for fiscal 2022 was $984.83K, a 25.42% increase from fiscal 2021.
- Rocket One Inc. other selling, general and administrative expense for fiscal 2021 was $785.21K.
| Period end | Other Selling, General and Administrative Expense 3 month | Other Selling, General and Administrative Expense 6 month | Other Selling, General and Administrative Expense 9 month | Other Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2023-09-30 | $67.10K 10-Q · filed 2023-11-13 | $113.27K derived: sum of 2 quarters · filed 2023-11-13 | $440.15K 10-Q · filed 2023-11-13 | $622.90K derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-06-30 | $46.17K 10-Q · filed 2023-08-11 | $373.05K 10-Q · filed 2023-08-11 | $555.80K derived: sum of 3 quarters · filed 2023-08-11 | $907.57K derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-03-31 | $326.88K 10-Q · filed 2023-05-15 | $509.63K derived: sum of 2 quarters · filed 2023-05-15 | $861.40K derived: sum of 3 quarters · filed 2023-11-13 | $1.10M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-12-31 | $182.75K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $534.52K derived: sum of 2 quarters · filed 2023-11-13 | $772.15K derived: sum of 3 quarters · filed 2023-11-13 | $984.83K 10-K · filed 2023-03-31 |
| 2022-09-30 | $351.77K 10-Q · filed 2023-11-13 | $589.40K derived: sum of 2 quarters · filed 2023-11-13 | $802.08K 10-Q · filed 2023-11-13 | $981.50K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $237.64K 10-Q · filed 2023-08-11 | $450.31K 10-Q · filed 2023-08-11 | $629.73K derived: sum of 3 quarters · filed 2023-08-11 | $835.83K derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $212.68K 10-Q · filed 2023-05-15 | $392.10K derived: sum of 2 quarters · filed 2023-05-15 | $598.19K derived: sum of 3 quarters · filed 2023-05-15 | |
| 2021-12-31 | $179.42K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $385.51K derived: sum of 2 quarters · filed 2023-03-31 | $785.21K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $206.09K 10-Q · filed 2022-11-10 | $605.79K 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |